ESC 365 - What we can learn from meta-analysis of the clinical trials of cell therapy - CON

Open Access

What we can learn from meta-analysis of the clinical trials of cell therapy - CON

Session: Controversies in cell therapies for myocardial infarction and heart failure

Topic: Cardiac Diseases

Speaker: Professor M. Gyongyosi (Vienna, AT)

Event: Frontiers in CardioVascular Biology 2018

Congress Presentation

Add to my library

About the speaker

Professor Mariann Gyongyosi

Medical University of Vienna, Vienna (Austria)

3 presentations

1 follower

3 more presentations in this session

Induced pluripotent stem cells (iPSCs) and their potential in regenerative medicine - PRO

Speaker: Professor J. Dulak (Krakow, PL)

Cell therapy for heart disease: unmet expectations - CON

Speaker: Professor P. Menasche (Paris, FR)

Cell based therapies for myocardial repair and regeneration in ischaemic heart disease and heart failure - PRO

Speaker: Associate Professor R. Madonna (Pisa, IT)

Access the full session

Controversies in cell therapies for myocardial infarction and heart failure

Speakers: Professor M. Gyongyosi, Professor J. Dulak, Professor P. Menasche, Associate Professor R. Madonna

About the event

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources